TB Vaccine Development: COVID-19 Pathways, mRNA Tech Hold Hope
Eyes On BioNTech-Gates Foundation Effort
With fast-tracked development and deployment of COVID-19 vaccines yielding results, experts call for similar urgency and funding impetus to progress new vaccines for TB, which still claims 4,000 lives daily. Over 15 candidates have been in development for years, with hope now abounding around the potential of new platforms like mRNA to accelerate efforts.
